Ready-to-Operate Cannabis Business with Established Offtake Agreements

Description

This pharmaceutical manufacturing facility operates in full compliance with SAPHRA and cGMP standards, providing a strong foundation for growth within the regulated healthcare sector. Equipped with modern production equipment and serving established clients in the United Kingdom, Germany, and Australia, the business benefits from an international customer base and proven operational capability.The facility's licence also permits third-party product manufacturing, creating additional revenue opportunities and increasing the potential for business expansion. This represents an attractive acquisition opportunity for investors seeking a compliant, scalable, and profitable pharmaceutical manufacturing operation.